1-[4-[3-chloro-4-[(3-fluorophenyl)methoxy]anilino]-8,9-dihydro-7H-pyrimido[5,4-h][1,5]benzoxazepin-6-yl]-4-(4-methyl-1-piperidyl)but-2-en-1-one

ID: ALA4641942

PubChem CID: 78322610

Max Phase: Preclinical

Molecular Formula: C34H35ClFN5O3

Molecular Weight: 616.14

Molecule Type: Unknown

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CC1CCN(C/C=C/C(=O)N2CCCOc3cc4ncnc(Nc5ccc(OCc6cccc(F)c6)c(Cl)c5)c4cc32)CC1

Standard InChI:  InChI=1S/C34H35ClFN5O3/c1-23-10-14-40(15-11-23)12-3-7-33(42)41-13-4-16-43-32-20-29-27(19-30(32)41)34(38-22-37-29)39-26-8-9-31(28(35)18-26)44-21-24-5-2-6-25(36)17-24/h2-3,5-9,17-20,22-23H,4,10-16,21H2,1H3,(H,37,38,39)/b7-3+

Standard InChI Key:  VKGUMIZUVXSFTB-XVNBXDOJSA-N

Molfile:  

 
     RDKit          2D

 44 49  0  0  0  0  0  0  0  0999 V2000
   24.3383  -24.8593    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   24.3375  -23.2220    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0464  -23.6297    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.0456  -24.4520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7568  -24.8600    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4692  -24.4509    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4660  -23.6255    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   25.7543  -23.2171    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   25.7515  -22.3958    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   26.4619  -21.9848    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1744  -22.3963    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8843  -21.9860    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.8820  -21.1638    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   27.1638  -20.7536    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   26.4568  -21.1704    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   28.5974  -22.3925    0.0000 Cl  0  0  0  0  0  0  0  0  0  0  0  0
   28.5919  -20.7477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   29.3056  -21.1570    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0114  -20.7410    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7222  -21.1544    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4316  -20.7390    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   31.4281  -19.9169    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.7094  -19.5118    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   30.0029  -19.9254    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   32.1451  -21.1487    0.0000 F   0  0  0  0  0  0  0  0  0  0  0  0
   23.6374  -23.6325    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6341  -24.4520    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9886  -24.9661    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.9930  -23.1170    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   22.1867  -24.7858    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.1889  -23.3002    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.8329  -24.0436    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   22.9887  -22.2994    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   23.6942  -21.8871    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   22.2788  -21.8946    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   21.5733  -22.3070    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.8634  -21.9021    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1579  -22.3145    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   19.4510  -21.9085    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7475  -22.3174    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.7477  -23.1349    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   19.4574  -23.5419    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   20.1670  -23.1314    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   18.0406  -23.5446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
 27  1  1  0
  1  4  2  0
  3  2  2  0
  2 26  1  0
  3  4  1  0
  4  5  1  0
  5  6  2  0
  6  7  1  0
  7  8  2  0
  8  3  1  0
  8  9  1  0
  9 10  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
 12 16  1  0
 13 17  1  0
 17 18  1  0
 18 19  1  0
 19 20  2  0
 20 21  1  0
 21 22  2  0
 22 23  1  0
 23 24  2  0
 24 19  1  0
 21 25  1  0
 26 27  2  0
 27 28  1  0
 26 29  1  0
 28 30  1  0
 29 31  1  0
 30 32  1  0
 31 32  1  0
 29 33  1  0
 33 34  2  0
 33 35  1  0
 35 36  2  0
 36 37  1  0
 37 38  1  0
 38 39  1  0
 38 43  1  0
 39 40  1  0
 40 41  1  0
 41 42  1  0
 42 43  1  0
 41 44  1  0
M  END

Associated Targets(Human)

NCI-N87 (850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
NCI-H1975 (4994 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
A-431 (6446 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
BT-474 (2113 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
Calu-3 (339 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
EGFR Tclin Epidermal growth factor receptor erbB1 (33727 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 616.14Molecular Weight (Monoisotopic): 615.2412AlogP: 7.15#Rotatable Bonds: 8
Polar Surface Area: 79.82Molecular Species: BASEHBA: 7HBD: 1
#RO5 Violations: 2HBA (Lipinski): 8HBD (Lipinski): 1#RO5 Violations (Lipinski): 2
CX Acidic pKa: CX Basic pKa: 8.58CX LogP: 6.31CX LogD: 5.11
Aromatic Rings: 4Heavy Atoms: 44QED Weighted: 0.21Np Likeness Score: -1.39

References

1. Sun M, Jia J, Sun H, Wang F..  (2020)  Design and synthesis of a novel class EGFR/HER2 dual inhibitors containing tricyclic oxazine fused quinazolines scaffold.,  30  (9): [PMID:32139324] [10.1016/j.bmcl.2020.127045]

Source